MENU

Cochlear faces potential price competition in China

Cochlear (ASX: COH) shares were down 4.8% on Thursday as investors considered potential threats to its Chinese market dominance. The Aussie world-beater has long been a beneficiary of the fast-growing Chinese healthcare market, however, the potential for increased competition saw a share price slide yesterday.

Media reports that Chinese company Nurotron Biotechnology will compete for lucrative government contracts on a low-cost basis are what spooked investors. Cochlear, though, bases its product price premium on industry-leading products in hearing loss healthcare.

It is not the first multi-national to face product competition from enterprising Chinese companies and it will continue to rely on its best-in-class reputation and technological edge to translate into increasing profits across global markets.

The company recently launched its latest hearing device, the Nucleus N6. It is said to be the start of an innovative new range of sound processing technologies, which it thinks will keep it ahead of the competition through 2014 and beyond.

Foolish takeaway

Home-grown competitors in foreign markets will always exist as a risk for Cochlear. Its competitive advantage lies with its technology, and maintaining this long-term should keep the future bright.

Interested in our #1 dividend-paying stock? Discover The Motley Fool’s favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of “The Motley Fool’s Top Dividend Stock for 2013-2014.”

More reading


Motley Fool contributor Tom Richardson owns shares Cochlear.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!